Skip to main content
Juniper Hotels Limited logo

Juniper Hotels Limited — Investor Relations & Filings

Ticker · JUNIPER ISIN · INE696F01016 LEI · 335800QBDPW1325RMY43 BSE.NS Accommodation and food service activities
Open in API
Filings indexed 209 across all filing types
Latest filing 2026-02-11 Regulatory Filings
Country IN India
Listing BSE.NS JUNIPER

About Juniper Hotels Limited

https://juniperhotels.com/

Juniper Hotels Limited is a luxury hotel development and ownership entity established through a strategic partnership between Saraf Hotels and Hyatt Hotels Corporation. The company focuses on the acquisition, development, and management of high-end hospitality assets. Its portfolio comprises several upper-upscale and luxury properties operated under various Hyatt brands, including Grand Hyatt, Andaz, Hyatt Regency, and Hyatt Centric. Key assets include the Grand Hyatt Mumbai and Andaz Delhi. The company serves the premium travel segment, offering comprehensive guest services, diverse culinary experiences, and extensive facilities for meetings, incentives, conferences, and exhibitions. Juniper Hotels emphasizes strategic asset positioning in major urban centers and maintains a long-term commitment to international hospitality standards through its collaborative operational framework.

Recent filings

Filing Released Lang Actions
Monitoring Agency Report
Regulatory Filings Classification · 95% confidence The document is a Monitoring Agency Report for the quarter ended December 31, 2025, related to the utilization of proceeds from the Initial Public Offer (IPO) of Juniper Hotels Limited. It is issued pursuant to SEBI regulations concerning disclosure and monitoring of IPO proceeds. The report includes detailed information on the use of funds, deviations, and certifications by a monitoring agency (CARE Ratings Limited). It is not a full annual or quarterly financial report, nor an earnings release or management discussion. It is a regulatory compliance report specifically monitoring IPO proceeds utilization, which aligns with the category of Regulatory Filings (RNS) as it is a mandated disclosure under SEBI regulations and does not fit other specific categories like Annual Report, Interim Report, or Capital/Financing Update. The document is substantive and not merely an announcement or certification letter, but it is a specialized regulatory disclosure report.
2026-02-11 English
Investor Presentation
Interim / Quarterly Report Classification · 100% confidence The document is dated February 11, 2026, and is addressed to stock exchanges in India, indicating a formal corporate communication. It presents a detailed "Result Analysis" for the quarter ended December 31, 2025, including unaudited standalone and consolidated financial results. The content includes extensive financial data such as revenue, EBITDA, profit before tax, segmental revenue breakdowns, operational metrics, and growth drivers. The document also contains an investor presentation with forward-looking statements and detailed financial performance highlights for Q3FY26. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive quarterly financial report rather than a brief announcement or a certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q3 2026
2026-02-11 English
Outcome of Board Meeting
Regulatory Filings
2026-02-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about an upcoming earnings conference call scheduled for February 11, 2026, to discuss Q3 FY26 results. It includes details such as date, time, participants, and dial-in numbers. There is no actual financial data or results presented, only an announcement of the call. According to the classification rules, such notifications are classified as Call Transcript (CT) only if they contain the full transcript of the call. Since this is only an intimation of the call, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit other categories. The document length is short and it is an announcement rather than a report or transcript.
2026-02-05 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-02-03 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a prior intimation of a Board Meeting scheduled for February 11, 2026, where the Board will consider and approve the unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. It is a notice sent to stock exchanges pursuant to SEBI regulations about the upcoming Board meeting and trading window closure. The document does not contain actual financial results or detailed financial data but is an announcement about the meeting where such results will be approved. Therefore, it is not an Interim/Quarterly Report (IR) itself but a regulatory announcement about the meeting. This fits the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-02-03 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.